/Lilly(Eli)%20%26%20Co%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of $789.4 billion. Eli Lilly is dedicated to discovering and delivering innovative treatments for complex health conditions, primarily focusing on diabetes, oncology, immunology, and neuroscience. Eli Lilly aims to improve patients' lives worldwide through cutting-edge research and development.
Shares of Eli Lilly have underperformed the broader market over the past year. The stock has gained 34.3% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 36.8%. However, in 2024, LLY is up 42.7% compared to SPX’s 25.7% rise on a YTD basis.